Daniel Beachler

Director
Safety & Epidemiology, HealthCore, Inc.

Presentation(s):

• SP01E - Factors Associated with Adherence to Newly Initiated JAK Inhibitors in Rheumatoid Arthritis Patients

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time

• SP05 - Spotlight Posters: Cancer

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time

• OP-1C - Comparative Safety of Conjugated Estrogens/bazedoxifene (CE/BZA) versus Estrogen/progestin Combination Hormone Therapy (EP): A Multi-database Cohort Study

  Wednesday, August 25, 2021
  4:30 PM – 6:00 PM US Eastern Time